Status:
COMPLETED
Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
Lead Sponsor:
Spanish Breast Cancer Research Group
Collaborating Sponsors:
Novartis Pharmaceuticals
Conditions:
Breast Carcinoma Metastatic to the Bone
Eligibility:
FEMALE
18+ years
Brief Summary
Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).
Detailed Description
Population: Patients over 18 with breast cancer and bone metastasis. Inclusion criteria: * Patient over 18 years of age. * Patient diagnosed with breast cancer (BC) and bone metastases (BM). * Patie...
Eligibility Criteria
Inclusion
- Patient over 18 years of age.
- Patient diagnosed with BC and BM.
- Patient who has granted informed consent in writing to participate in the study.
- Patient capable of understanding and completing the questionnaires
Exclusion
- Patient with another type of disease that, in the investigator's opinion, could mask the study results.
- Patients with a life expectancy of less than 8 months.
- Patient who is participating in a clinical trial with an unregistered drug at the start of the study.
Key Trial Info
Start Date :
October 23 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2012
Estimated Enrollment :
241 Patients enrolled
Trial Details
Trial ID
NCT03847220
Start Date
October 23 2007
End Date
July 7 2012
Last Update
March 6 2023
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen Del Rocío
Seville, Andalusia, Spain, 41013
2
Hospital General de Guadalajara
Guadalajara, Castille-La Mancha, Spain, 19002
3
ICO Badalona Hospital Universitari Germans Trias I Pujol
Badalona, Catalonia, Spain, 08916
4
Hospital Universitari Clinic I Provincial
Barcelona, Catalonia, Spain, 08036